Filing Details
- Accession Number:
- 0001562180-25-002636
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-20 18:11:24
- Reporting Period:
- 2025-03-19
- Filing Date:
- 2025-03-20
- Accepted Time:
- 2025-03-20 18:11:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1231427 | Christopher Patusky | C/O United Therapeutics Corporation 1000 Spring Street Silver Spring MD 20910 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-03-19 | 5,000 | $175.43 | 5,900 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-03-19 | 300 | $307.73 | 5,600 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-19 | 1,780 | $308.82 | 3,820 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-19 | 328 | $309.73 | 3,492 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-19 | 457 | $310.80 | 3,035 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-19 | 736 | $312.22 | 2,299 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-19 | 1,299 | $313.14 | 1,000 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-19 | 100 | $313.77 | 900 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2025-03-19 | 5,000 | $0.00 | 5,000 | $175.43 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2016-06-26 | 2025-06-26 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,100 | Indirect | by Trust |
Footnotes
- This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 27, 2024.
- This transaction was executed in multiple trades at prices ranging from $307.32 to $308.125. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $308.44 to $309.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $309.48 to $310.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $310.48 to $310.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $311.68 to $312.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $312.735 to $313.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
